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Protein–protein interactionp62, also known as SQSTM1, is a multi-domain signalling scaffold protein involved in numerous critical cellular
functions such as autophagy, apoptosis and inﬂammation. Crucial interactions relevant to these functions are
mediated by the N-terminal Phox and Bem1p (PB1) domain, which is divided into two interaction surfaces,
one of predominantly acidic and one of basic character. Most known interaction partners, including atypical
protein kinase C (aPKC), bind to the basic surface, and acidic–basic interactions at this interface also allow for
p62 homopolymerisation. We identify here that the coupling of p62 to the cAMP signalling system is con-
ferred by both the direct binding of cAMP degrading phosphodiesterase-4 (PDE4) to the acidic surface of
the p62 PB1 domain and the phosphorylation of the basic surface of this domain by cAMP-dependent pro-
tein kinase (PKA). Such phosphorylation is a previously unknown means of regulating PB1 domain interaction
partnerships by disrupting the interaction of p62 with basic surface binding partners, such as aPKCs, as well as
p62 homopolymerisation. Thus, we uncover a new regulatory mechanism that connects cAMP signalling with
the p62 multi-domain signalling scaffold and autophagy cargo receptor protein.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The signalling adaptor p62/SQSTM1 regulates important cellular
functions, such as apoptosis and inﬂammation, but is best known for
its role in the orchestration of events involved in autophagy [1]. The
vital scaffolding function of p62 is underpinned by its ability to complex
with a variety of other regulatory proteins by virtue of the different
interaction domains it contains. These include the atypical zinc ﬁnger
(ZZ) domain, Light Chain 3 (LC3) interacting region [2] and TRAF6-
binding and ubiquitin-associated (UBA) domains [1]. p62 also contains
an N-terminal Phex and Bem1p (PB1) domain [3]. The PB1motif allows
p62 to interact with other PB1 domain-containing proteins and with
itself via hetero- and homo-dimerisation (or -polymerisation). A PB1
domainmay contain twodifferent conservedmotifs to allow for interac-
tion with binding partners. One of them, the OPCA motif, consists of a, cyclic AMP-dependent protein
ain 3; MEK, mitogen-activated
BR, neighbour of BRCA1 gene 1
tif; PB1, Phox and Bem1p; PDE,
se; SQSTM1, sequestosome-1;
-associated domain; UCR, up-
llie).conserved cluster of acidic amino acids, with the complement in
the interacting partner provided by a conserved lysine residue
within a predominantly basic cluster. These conserved clusters
are sometimes referred to as A-type (acidic) and B-type (basic).
Some proteins, such as p62, contain both conserved motifs,
allowing for homo-polymerisation.
In autophagy, p62 plays the role of a cargo receptor by detecting
ubiquitinated substrates using its UBA domain [4,5], aggregating them
through PB1-mediated homo-polymerisation and attaching them
to the autophagosome by association with LC3 [2,6]. Autophagosomes
then fuse with lysosomes, thus degrading the former autophagy sub-
strates, releasing amino acids and other nutrients as new building
blocks for the cell.
Apart from the homopolymerisation of p62, many of its interaction
partners bind to p62 via heterodimeric PB1 domain interactions, involv-
ing the conserved basic cluster in p62 that includes Lys7, Arg21 and
Arg22 [7] together with the OPCA motif in the interaction partner.
Examples of proteins that form a complex with p62 in this manner in-
clude the atypical PKC (aPKC) isoforms, PKCλ/ι and PKCζ [8,9], TRAF6
[8] and MEK5 [10]. In addition to these “p62-basic cluster-binders”,
MEKK3was recently identiﬁed as the ﬁrst protein, apart from p62 itself,
to bind in the converse fashion, i.e. by binding to the OPCA motif/acidic
cluster of p62. It is thought that this mechanism allows MEKK3, but not
MEKK2, to activate NF-κB signalling selectively via its association with
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are regulated.
We have shown recently that p62 interacts with the cyclic AMP-
degrading phosphodiesterase, PDE4A4 [11,12]. This enzyme is a mem-
ber of the PDE4 family of phosphodiesterases, comprising N25 isoforms
encoded by 4 genes inmammals. The different isoformsof PDE4 interact
with an arrayof signallingproteins, such as protein kinases and scaffold-
ing proteins, and they are sequestered in this way to distinct subcellular
locales, predominantly by interactionsmediated through their isoform-
speciﬁc N-termini [13]. This localisation allows cAMP signalling com-
partmentation, where the stimulus cAMP, its effectors such as cAMP-
dependent protein kinase (PKA) and substrates thereof are brought
closely together in one protein complex. The action of distinct PDE4
isoforms results in the production of stimulus-speciﬁc, subcellularly
conﬁned cAMP gradients. Such gradients promote the transient activa-
tion of the cAMP effector proteins, PKA, exchange proteins activated
by cAMP (Epac) and cyclic nucleotide-gated (CNG) ion channels,
which leads to distinct changes in cell function [14]. In the case of PKA,
the enzyme recognises substrates in its vicinity through a consensus
motif R–R/K–X–S/T in their amino acid sequence [15], wherein the ser-
ine or threonine is phosphorylated to bring about a change in function.
In this report we show, for the ﬁrst time, that PDE4 can interact
directly with the p62 PB1 domain by binding to the p62 OPCA motif.
Furthermore, we identify a novel PKA phosphorylation site within the
p62 PB1 domain and demonstrate that it regulates the binding interac-
tion of certain partner proteins. Taken together, these observations are
the ﬁrst indication that cAMP signals can cross-talk with the well-
established signalling functions of p62. We suggest that this opens
up a novel regulatory mechanism for both the homopolymerisationFig. 1. PDE4A4 and p62 interact directly. (A) Full-length puriﬁed MBP-p62 and GST-PDE4A4 i
PDE4A4. Free binding sites were blocked, and increasing concentrations (1–512 nM) of MB
using an anti-MBP-HRP conjugate and a chemiluminescence substrate. (B) A peptide array rep
reveals interaction of the PDE with the OPCA motif (underlined) located within the PB1 doma
HRP conjugate. (C) A peptide array alanine scan across the p62 OPCA motif (spot A13 from pa
for PDE4A4 binding. The bottom line summarises amino acids essential for PDE4A4 binding (
in other PB1 domains (underlined).of p62 (which is a prerequisite for autophagosome formation)
and its binding to other partners involved in signalling pathways af-
fecting nutrient homeostasis, immunological responses and cancer
development.
2. Results
2.1. PDE4A4 binds directly to p62
p62 associates constitutively with the cAMP degrading PDE4A4
isoform in cells and this is required for the reversible intracellular redis-
tribution of PDE4A4 into aggregates that is elicited by chronic exposure
to certain PDE4-speciﬁc inhibitors, such as rolipram, that promote
‘capping’ of the active site by the regulatory UCR2 domain [11,12,16].
Initially, we set out here to determine whether the interaction
between p62 and PDE4A4 is direct. To do this we developed an
ELISA-based assay using puriﬁed recombinant full length MBP-p62
and GST-PDE4A4 proteins (Fig. 1A). We detected increases in chemi-
luminescence only when increasing amounts of MBP-p62 were com-
bined with GST-PDE4A4. This was not the case for any combination
including GST or MBP alone, suggesting that the MBP and GST tags
were not involved in the interaction between p62 and PDE4A4 and
that the two proteins interact directly. To support the notion of a
direct interaction between p62 and PDE4A4 and to gain insight into
the nature of the interaction sites between the proteins, we utilised
peptide array technology [17]. Peptide array technology has been
used successfully by us to map the interfaces between interacting
proteins (see e.g. [18,19]). In order to map the sites of interaction be-
tween p62 and PDE4A4, we synthesised a peptide array representingnteract directly in an ELISA. 384 well microplates were coated with 256 nM GST or GST-
P or MBP-p62 were added to the wells. After washing, the bound protein was detected
resenting the full length sequence of p62 screened with puriﬁed GST-PDE4A4 (5 μg/ml)
in of p62, spanning amino acids 58 to 87. Bound protein was detected using an anti-GST-
nel B) overlaid with GST-PDE4A4 (5 μg/ml) reveals essential amino acids of p62 required
in bold) versus those essential for the interactions of the OPCA motif with the basic motif
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encompassed the entire p62 sequence (Fig. 1B). We then probed this
array with either GST or GST-PDE4A4 and detected areas of interaction
by blotting for the GST tag. A robust interaction of GST-PDE4A4 (but not
GST alone) was identiﬁed on peptide spots A12 and A13, which corre-
spond to amino acids 58–87 within the p62 sequence (Fig. 1B). This
part of the sequence is located within the Phox and Bem1p (PB1)
domain, an evolutionarily well-conserved protein interaction domain
[3] located at the N-terminus of p62. The sequence contained within
the interacting peptides (A12, A13) contains the OPCA motif of the
PB1 domain, which is known to be essential for interaction with other
PB1 domain-containing proteins via its conserved cluster of acidic
amino acids. A detailed alanine scan of this region, where successive
residues were substituted with alanine residues (with endogenous
alanine residues replaced by aspartate), shows that the major relevant
residues involved in the interaction are Phe63, Tyr67, Glu70, Asp71,
Asp73, Leu74 and Tyr77 (Fig. 1C). Hence, two of the aspartates con-
served in OPCAmotifs, Asp71 and Asp73, appear to be crucial for the in-
teraction, while the conserved Asp69 and Glu82 are not.Fig. 2. PKA phosphorylates p62 at Ser24. (A–C) In vitro phosphorylation of p62 by PKA. (A) A
overlapping 25mers was incubated with recombinant PKA catalytic subunit and γ-32P-ATP. P
well as all other sites resembling the PKA consensus site RXXS/T were synthesised as wildtype
array was then PKA-phosphorylated and detected as in (A). (C) Full length MBP fusion proteins
were incubated with γ-32P-ATP and with (+) or without (−) recombinant puriﬁed PKA catal
carried out. (D–F) In vivo phosphorylation of p62 by PKA. (D) Rat PC12 cells were stimulated
were prepared, and immunoprecipitated with IgG or a p62-speciﬁc antibody. After cysteines w
and stained with Coomassie blue. A band of approx. 62 kDa present in the p62-IPs, but not in
The protein was digested with trypsin and analysed by nanoLC–MS/MS. The peak with m/z 88
sequence 22–44 (mcalc 2648.083) of p62. C-terminal fragment ions (y4–y11) of the CID spectrum
b9) indicate phosphorylation in vivo at serine 24 after forskolin + rolipram treatment. C*, cys
electrostatic surface potential and position of Ser24 (orange) within the conserved basic motif
[50]).Consequently, p62 is a new example for a signalling scaffold protein
binding a PDE4 isoform directly.
2.2. p62 is phosphorylated at Ser24 by PKA
Intrigued by this ﬁnding, and by previous studies where we found
scaffolding proteins to bind PDE4 isoforms as well as PKA substrates,
allowing for regulation of substrate phosphorylation [20,21], we were
curious whether p62 or one of its interaction partners could be a PKA
substrate. Indeed, upon examining the amino acid sequence of p62
we noticed an optimal PKA consensus phosphorylation sequence 21-
RRFS-24 [15] within the PB1 domain. In order to see if PKA can phos-
phorylate the serine within this motif (Ser24), a peptide array covering
the full-length sequence of p62 was incubated with puriﬁed, recombi-
nant PKA catalytic subunit and γ-32P-ATP, followed by autoradiography
(Fig. 2A). The ﬁrst ﬁve peptides on the array contained the PKA phos-
phorylation motif and were phosphorylated by PKA. Phosphorylation
was not observed with the adjacent peptides (from peptide 6), suggest-
ing that Ser24 can be phosphorylated by recombinant PKA in vitro. Thispeptide array covering the sequence of the N-terminal 50 amino acids of human p62 by
hosphorylation was detected by autoradiography. (B) The Ser24 phosphorylation site as
25mer peptides, or with the phospho-target amino acid replaced by alanine. The peptide
of p62, p62-S24A and PDE4A4were expressed in E. coli and puriﬁed. 2 mg of each protein
ytic subunit, and then run by SDS-PAGE. A Coomassie staining and autoradiography were
for 10 min with forskolin and rolipram or left untreated (control and IgG). Cell lysates
ere reduced and modiﬁed by carbamidomethylation, IP eluates were separated on a gel
the IgG control, was excised (dashed box) and subjected to mass spectrometric analysis.
3.713 in the MS spectrum (E) corresponds to the triply charged ion of the phosphorylated
(F) conﬁrm the phosphorylated amino acid sequence, whereas the b ions (b3–98, b6, and
teines are alkylated by iodoacetamide. (G) Structure of the p62 PB1 domain showing the
(based on the PDB-deposited structure, 2KKC [25], and modiﬁed using Swiss-PdbViewer
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alanine, and which cannot be phosphorylated in this way (Fig. 2B). The
same holds true for homologous sequences frommouse and rat p62. As
an additional control, all other sequences from human, mouse and rat
p62 containing other putative (though non-ideal) PKA phosphorylation
consensus sequences were synthesised and probed in the same way
(Fig. 2B). Only peptides containing the PKA phosphorylation motif
that incorporates Ser24 were found to be PKA substrates, suggesting
that Ser24 is the sole PKA site within p62.
As short peptide substrates might be subject to non-speciﬁc kinase
action, and the target Ser24might be less accessible in a full-length pro-
tein due to conformational hindrance, we puriﬁed recombinant full
length MBP-p62 and a S24A mutant thereof. Both MBP-p62 wild type
and the S24A mutant, as well as MBP-PDE4A4, which is an established
PKA substrate [22] and therefore serves as a positive control, were incu-
batedwith the PKA catalytic subunit andγ-32P-ATP, followed by autora-
diography (Fig. 2C). Phosphorylation of MBP-PDE4A4 and MBP-p62 at
the corresponding molecular weights was observed. Phosphorylation
of the S24Amutant of MBP-p62was reduced strongly, with the residual
phosphorylation likely to be caused by non-speciﬁc phosphorylation of
the fused MBP moiety that, on its own, appeared as a weak intensity
band (Fig. 2C lower panel).Fig. 3. Phosphorylation of p62 at Ser24 in cells is PKA-dependent. (A) The p62 PB1 domain
untransfected (−) or transiently transfected with equal amounts of ﬂag-p62-wt (wt), -K7A/D
100 μM forskolin for 5 min as indicated. Lysates were prepared and analysed by Western blot
ditions, p62-K7A/D69A is stronger phosphorylated at Ser24 than p62-wt. Quantiﬁcation for
(C) Forskolin evokes a slow phosphorylation of p62 at Ser24. HEK293 cells were transiently tr
forskolin for the indicated times. Lysates were prepared and analysed by Western blot using s
shows phospho-p62 normalised to total p62 band intensity. (D) p62 phosphorylation at Se
HEK293 cells were transiently transfected with equal amounts of ﬂag-p62-wt or -S24A in co
forskolin for the indicated times. Lysates were prepared and analysed by Western blot using spThough recombinant PKA catalytic subunit is representative of both
the activity and speciﬁcity of PKA in vivo [23,24], to determine whether
the observed p62-Ser24 phosphorylation also takes place in a cellular
context, and to further validate Ser24 as a bona ﬁde PKA substrate, we
subjected p62 immunopuriﬁcations to analysis by mass spectrometry.
Immunopuriﬁcation of p62 from rat pheochromocytoma (PC12) cells
was undertaken following either no treatment or treatment with the
adenylyl cyclase activator, forskolin (100 μM), and the PDE4 inhibi-
tor, rolipram (10 μM). Gel bands corresponding to the molecular
weight of p62 were cut from a Coomassie-stained gel (Fig. 2D) and
proteins were in-gel digested by trypsin. Nano-liquid chromatogra-
phy–tandem mass spectrometry (nanoLC–MS/MS; Fig. 2E and
F) unambigously identiﬁed a tryptic peptide corresponding to
Ser24-phosphorylated p62 in the forskolin/rolipram-treated immu-
noprecipitate but not in the untreated cells. Such data indicates
that the PDE4A4 activity associated with p62 may regulate phos-
phorylation at this site on p62 within cells.
Bioinformatic analysis was then carried out to provide insight into
the molecular location of this novel PKA phosphorylation site in p62
and the possible consequences due to such phosphorylation. The NMR
solution structure of the p62 PB1 domain [25] was used to locate the
position of Ser24 on the surface of the protein domain. It was foundis both necessary and sufﬁcient for phosphorylation at Ser24. HEK293 cells were left
69A (m), -ΔPB1 or the p62 PB1 domain alone (PB1). After 24 h, cells were treated with
using speciﬁc ﬂag- or p62-pS24 antibodies as indicated in the ﬁgure. (B) Under basal con-
m (p62-K7A/D69A) from panel A. Statistical analysis by paired t-test n = 3, P = 0.03.
ansfected with equal amounts of ﬂag-p62-wt. After 24 h, cells were treated with 100 μM
peciﬁc p62-, p62-pS24 or GAPDH antibodies as indicated in the ﬁgure. The quantiﬁcation
r24 peaks after forskolin stimulation for 24 h and is blocked by PKI or a S24A mutant.
mbination with either pcDNA3 or myc-PKIα. After 24 h, cells were treated with 100 μM
eciﬁc p62-, p62-pS24 or GAPDH antibodies as indicated in the ﬁgure.
2769F. Christian et al. / Biochimica et Biophysica Acta 1843 (2014) 2765–2774to be within the largely basic (positively charged) region around the
conserved Lys7 (Fig. 2G). Hence, as phosphorylation of Ser24
would introduce a negatively charged phosphate group at the site,
it is likely that this would change its electrostatic potential and that
this might serve to affect the binding of partner proteins through
electrostatic interactions. This has been shown to be the case for
PB1–PB1 interactions involving the conserved basic and acidic
(OPCA) motifs [7,26,27]. Indeed, when the electrostatic surface poten-
tial was calculated for the PB1 domain, it was found that the phosphory-
lated Ser24 can be expected to change the electrostatic appearance of the
basic motif surface (Fig. 2G).
Intrigued by this ﬁnding, and in order tomonitor the dynamic phos-
phorylation of p62 at Ser24 directly, we raised a phospho-speciﬁc anti-
body against the Ser24 site (Fig. S2). To validate the antibody, and to
prove further that the Ser24 site is the sole point of PKA phosphoryla-
tion on p62,we transfectedHEK293 cellswith plasmids encoding differ-
ent ﬂag-tagged p62 constructs: a full length wild type p62 (wt); a
mutant containing the double substitution K7A and D69A within the
PB1 domain which has been shown to disable polymerisation of p62
(m) [7]; a truncated p62 with the PB1 domain (amino acids 1–101)
deleted (ΔPB1); or a construct corresponding to only the PB1 domain
of p62 (PB1) (Fig. 3A). Cells were then either treated with forskolin
(50 μM) alone for 5min or left untreated. Cell lysateswere subsequently
probed with the p62-pS24 antibody (Fig. 3A, lower panel) and a FLAG
antibody (Fig. 3A, upper panel). Although expression of all constructs
was conﬁrmed using the FLAG antibody, phospho-bands were only
detected for the wild type (wt), the non-polymerising mutant
(m) and the PB1 domain alone (PB1). Phosphorylation at S24 was not
apparent for the p62 construct lacking the PB1 domain (ΔPB1). These
data suggest that the p62 PB1 domain is both necessary and sufﬁcient
to promote p62 phosphorylation by PKA. Surprisingly, forskolin treat-
ment alone failed to trigger an increase in Ser24 phosphorylation in ei-
ther the wild type or PB1 only constructs. The K7A/D69A non-
polymerisingmutant (Fig. 3B), however, showed signiﬁcantly increased
Ser24 phosphorylation under basal conditions.We hypothesise that po-
lymerisation of the PB1 domain physically restricts access of PKA to the
S24 phosphorylation site, resulting in a dramatic reduction of this post-
translational modiﬁcation.
We also evaluated the time-dependency of p62 phosphorylation
at the Ser24 site in forskolin-challenged HEK293 cells expressing
ﬂag-tagged p62 (Fig. 3C), showing that this reached a maximum after
a 2 h period. To see whether phosphorylation increases further after
2 h forskolin stimulation, we increased the timecourse to 48 h. This
revealed a maximum at 24 h (Fig. 3D). At the same time, in order to
demonstrate that this action was PKA-speciﬁc we co-transfected cells
with PKI, a potent and highly selective inhibitor of PKA [28]. Consistent
with this action being mediated by PKA, we found that PKI ablated the
forskolin-induced phosphorylation of p62 at Ser24 across the whole
timecourse (Fig. 3D). The speciﬁcity of the Ser24 phosphorylation site
was further conﬁrmed by a S24Amutant p62 that under the same con-
ditions was not phosphorylated at all.
Other AGC kinases have similar substrate consensus sequences to
that of PKA. For example, Akt/PKB kinase has the consensus motif
RXRXXSφ, with φ denoting a bulky hydrophobic residue [29]. However,
stimulation of HEK293 cells with insulin, the prototypical Akt activator
[30], did not lead to any detectable phosphorylation of p62 at Ser24
(Fig. S1), even though Akt itself was clearly activated under these condi-
tions, as measured by its phosphorylation at Ser473 [31].
2.3. Phosphorylation at Ser24 regulates p62 polymerisation and PB1
interaction partner binding
We propose that the functional relevance of Ser24 phosphorylation
of p62 by PKA is the introduction of a negatively charged phosphate
group to the basic surface of the OPCA motif leading to a disruption of
the PB1 domain interaction partner binding through electrostaticinterference (Fig. 4A). To address this, we introduced S24A (phospho-
null) and S24D (phospho-mimic) mutations into a cherry-tagged p62
wild-type construct.
Work from other groups has shown that p62 forms cytoplasmic
bodies both endogenously and when overexpressed in cells and that
this process requires both the PB1 and the UBA domains [2,32]. Consis-
tent with this we observed extensive cytoplasmic body formation in
HEK293 cells expressing either recombinant wild-type or mutant
S24A cherry-tagged p62 (Fig. 4B, upper and middle panel). Strikingly,
however, this was not evident when cells were transfected with the
PKA phospho-mimicking cherry-tagged p62-S24D, which exhibited a
dispersed distribution in the cytoplasm (Fig. 4B, lower panel). This sug-
gests that the single PKA phospho-mimicking mutation sufﬁces to pre-
vent p62 polymerisation.
We then set out to determine whether the binding of other interac-
tion partners of the p62 PB1 domain was affected by the phospho-
mimicking S24D mutation. We used such a mutation as it reﬂects a
homogeneous population of fully phosphorylated p62, which would
be difﬁcult to realise using forskolin-challenged cells where p62 is
slowly phosphorylated and there will be a mixture of phosphorylated
and non-phosphorylated species. Thus we carried out a series of co-
immunoprecipitation (IP) experiments using either cherry-p62-S24A,
which mimics the fully de-phosphorylated state at Ser24, or S24D,
which mimics the fully phosphorylated state at Ser24. Such immuno-
precipitates were then subject to Western blotting using speciﬁc
antisera to established endogenous interaction partners of p62 ([7,
33]; Fig. 4C).
Doing this we found that various proteins that are known to bind to
the p62 PB1 domain basic motif, namely NBR1, PKCι, PKCζ and MEK5,
while co-immunoprecipitating with the S24A p62 mutant, failed to
bind to the S24Dp62mutant (Fig. 4C). This suggests that PKAphosphor-
ylation of S24 regulates the binding of those partner proteins to p62 that
require the PB1 interface.
In order to test this hypothesis we evaluated the binding of LC3,
which is known to bind to a distinct region on p62, which has been
termed the LC3-interacting region (LIR; [32]). Investigating LC3 interac-
tion,we found that LC3 co-immunoprecipitatedwith both the S24A and
S24Dmutant p62 constructs, although bindingwas somewhat lesswith
the S24Dmutant. PDE4A4 also binds to a different surface patch on p62,
namely the acidic, rather than the basic domain of the PB1 interface
(Fig. 1B). As endogenous PDE4A5 (the rodent orthologue of human
PDE4A4) is only expressed at vanishingly low levels in PC12 cells we
used the HEK293-PDE4A4 cell line, which stably overexpresses
PDE4A4 (Fig. 4D). When transfecting these cells with tagged p62 mu-
tants, we found that both the S24A and the S24Dmutant p62 constructs
exhibited similar abilities to bind PDE4A4 (Fig. 4D). This observation
was reinforced using an in vitro ELISA assay that evaluated the associa-
tion between MBP, MBP-p62-wt and -p62-S24D to GST-PDE4A4
(Fig. 4E). Using this approach we found that the p62-wt and -S24D pro-
teins exhibit very similar binding characteristics to PDE4A4, while MBP
alone does not bind at all.
3. Discussion
We report here the discovery of cAMP degrading PDE4A4 as a new
interaction partner for the signalling adaptor p62/SQSTM1.We propose
that this protein complex represents a previously undiscovered point of
cross-talk between the cAMP signalling system and p62-regulated pro-
cesses. In this, sequestered PDE4A4 may inﬂuence access of cAMP to
PKA able to phosphorylate p62 and, thereby, selectively regulate its in-
teraction with certain partner proteins.
Peptide mapping of the interaction sites between p62 and PDE4A4
allowed us to identify a well deﬁned binding site on p62 encompassing
the conserved acidic OPCA motif (amino acids 58–87), which is
known to be crucial for PB1 domain interactions. So far, only two
interaction partners have been shown to bind that part of the p62
Fig. 4.Mimicking phosphorylation at p62-Ser24 determines polymerisation and interaction partner binding. (A) Schematic of the p62 PB1 domain and known interaction partners of its
basic and acidic surfaces. (B) S24D mutation of cherry-p62 causes a dispersed phenotype inside cells. HEK293 cells were transfected with cherry-p62-wt, -S24A or -S24D and analysed
using a ﬂuorescence microscope 24 h later. While p62-wt and -S24A are present in large aggregates, p62-S24D is dispersed throughout the cytosol. Images are representative for exper-
iments done independently at least 3 times. Statistical analysis by one-wayANOVA (allmeans): n=3, P= 0.0072, and by unpaired t-test (p62-wt vs. -S24A): n=3, P= 0.5073. (C) S24D
mutation of p62 speciﬁcally disrupts binding to established interaction partners of the PB1 domain. PC12 cells were transfected with either cherry-p62-S24A or -S24D. After 24 h, lysates
were prepared and immunoprecipitated using IgG or a p62-speciﬁc antibody. After washing, lysates and eluates from the IPs were separated by SDS-PAGE and blotted onto PVDF mem-
branes. Themembranes were detected using speciﬁc antibodies as indicated in the ﬁgure. LC3 is a known p62 interaction partner, but it binds outside the PB1 domain. Blots are represen-
tative for experiments done independently at least 3 times. (D) p62-S24A and -S24D both co-immunoprecipitate PDE4A4. HEK293 cells stably transfected to express PDE4A4 (lower
panel) were transfected and analysed as in (C). Blots were detected using a PDE4A4-speciﬁc antibody. (E) MBP-p62-wt and -S24A display similar binding afﬁnities in an ELISA using mi-
croplates coated with GST-PDE4A4. Experimental procedure as in Fig. 1A.
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mitogen-activated protein kinase kinase kinase, MEKK3 [10]. Com-
parison of binding motifs for the established p62 partners against
those utilised by PDE4A4 suggests that PDE4A4 binds in a novel fash-
ion to the OPCA motif of the p62 PB1 domain. The scanning alanine
replacement peptide array (Fig. 1C) showed that PDE4A4 is utilising
some (Asp71 and Asp73), but not all, of the conserved acidic amino
acid residues of the PB1 domain. Furthermore, the array suggests
that the binding of PDE4A4 to p62 utilises additional non-acidic
amino acids previously unknown to be involved in other PB1 domain
interactions (Phe63, Tyr67, Glu70, Leu74 and Tyr77). There is no
sequence homology between PDE4 proteins and any other PB1
domain protein sequence, supporting the notion of a unique binding
mode. The uniqueness of the interaction, along with a well deﬁned
short binding region, could be exploited to develop highly speciﬁc
peptide disruptors for use as a therapeutic or research tool to further
probe the functional relevance of the p62–PDE4A4 interaction. We
have recently developed such agents for other PDE containingprotein complexes that have potential as therapeutics in both the
oncology and cardiovascular disease ﬁelds [18,19,34].
The PKA substrate consensus sequence identiﬁed in p62 PB1 domain
conforms to the most common physiological motif, RRXS [35] and the
PKA speciﬁc inhibitor PKI ablates phosphorylation at this site (Fig. 3D).
Indeed, our mass spectrometric analysis (Fig. 2D–F) identiﬁed the phos-
phorylated p62 sequence 22–44 (RFS(phos)FCFSPEPEAEAAAGPGPCER),
containing such motif, suggesting p62 is a physiological substrate
of PKA. Furthermore, we ruled out Akt/Protein kinase B as a repre-
sentative for other AGC kinases, some of which have similar
substrate consensus sequences, as the responsible kinase for p62-
Ser24 phosphorylation, as insulin stimulation did not induce mea-
surable p62 phosphorylation over up to 48 h (Fig. S1). Taken togeth-
er, the evidence presented here suggests, for the ﬁrst time, that p62
is a substrate for PKA.
There are two clear primary functional outcomes of the p62 phos-
phorylation at Ser24 by PKA that go along with each other: one is the
effect on homopolymerisation, and the other is the selective action on
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we will detail these primary outcomes, along with possible secondary
consequences.
Wewere intrigued by the fact that the Ser24 PKA site is positioned at
the centre of the basic cluster of the OPCA region, close to K7, R21 and
R22 (Fig. 2G). K7 is highly conserved across B-type PB1 domains, and
it is crucial for interaction with A-type domains, akin to the ones that
underpin homopolymerisation [26]. R21 and R22, which are also part
of the PKA substrate consensus sequence, were found to be crucial for
the interaction of p62 with PKCλ [7] and it is likely that PKA phosphor-
ylation of p62 would negate this interaction. As Ser24 sits within the
p62 polymerisation interface, phosphorylation represents a dynamic
and controllablemeans to regulate polymerisation,with possible conse-
quences for autophagy initiation (see below). Conversely, the degree of
p62 phosphorylation at Ser24 should be affected by the scaffold's
homopolymerisation state. Our data ﬁts with this model, as a K7A/
D69A mutant blocks polymerisation, results in better PKA access to
Ser24 and leads to increased phosphorylation (Fig. 3B). Furthermore,
our assumptions based on the model (Fig. 2G) with regards to interac-
tion partner binding appear to be correct as p62 homopolymerisation
is blocked in a S24D phosphomimic p62 (Fig. 4B). Likewise, NBR1,
PKCι, PKCζ and MEK5, all binding to the basic B-type part of the p62
PB1 domain, do not bind to p62-S24D (Fig. 4C).
The most direct and obvious outcome of p62 phosphorylation on
Ser24 is its effect on p62 homopolymerisation, which has been found
to be required for one of the earliest steps in autophagy, the transloca-
tion of p62 (with its cargo) to the site of autophagosome formation
[36]. It is possible that the cell can adjust the level of speciﬁc p62-
dependent autophagy via cAMP and PKA activation. NBR1 has been
shown recently to act as an alternative autophagy receptor, either
alone or in conjunction with p62 [6,37], so it seems feasible that phos-
phorylation of the PB1 domainmay reduce p62- or NBR1-mediated spe-
ciﬁc autophagy. It is noteworthy that suppression of autophagy leads to
p62- and ubiquitin-positive aggregates. Such aggregates are also found
in pathological states such as neurodegenerative diseases (Alzheimer's,
Parkinson's, amyotrophic lateral sclerosis), liver disorders (alcoholic
hepatitis, steatohepatitis) and cancers (malignant glioma and hepa-
tocellular carcinoma) [38]. Consequently, in addition to p62 and the
ubiquitination machinery, cAMP signalling could be misregulated in
these cases, leading to hyperphosphorylation of p62 at Ser24, sup-
pression of homopolymerisation and hence a reduction in autopha-
gy. Interestingly, recent data from the yeast S. cerevisiae shows that
increased cAMP/PKA activity blocks autophagy [39], and that inacti-
vation of the cAMP pathway induces autophagy [40]. However, yeast
do not express p62 or homologues thereof, and the autophagy-
regulating protein Atg13 was identiﬁed as the responsible PKA sub-
strate in this case. It is also worth mentioning that the three PKA sub-
strate sites of Atg13 are not conserved in the human homologue, so it
is probable that a different point of signalling crosstalk exists in
mammals.
A recent, comprehensive analysis of p62 phospho-substrates found
that autophagy is regulated through posttranslational modiﬁcation of
p62, with phosphorylation at Ser403 by casein kinase 2 increasing the
interaction with ubiquitinated autophagy substrate proteins [41]. The
same study found Ser24 to be phosphorylated, however no kinase
and no functional consequences of its phosphorylation were identi-
ﬁed. The authors also found that Baﬁlomycin A1 (an autophagosome–
lysosome fusion inhibitor) did not induce this phosphorylation, sug-
gesting that phospho-Ser24 does not induce autophagy, which is in
line with our results as we propose that this modiﬁcation acts, instead,
to inhibit homopolymerisation (Fig. 4B), a requirement for autophagy
[36]. A further example of p62 regulation through phosphorylation is
found in the interplay between the Keap1–Nrf2 system and autophagy.
In this case, S351 is phosphorylated in a mTORC1-dependent fashion,
regulating the host defence mechanism and oxidative stress response
[42].Another major cellular pathway in which p62 has a pivotal role is the
NF-κB signalling system. The underlying mechanism involves PB1-
mediated binding of atypical PKC isoforms to p62 [9,33]. One route lead-
ing to downstreamactivation of NF-κB, is the phosphorylation and inhibi-
tion of IκB kinase β (IKKβ) through the aPKCs [43]. It is thought that p62
provides an essential scaffold to organise the signalling pathway by bind-
ing either receptor interacting protein 1 (RIP1), which is connected to the
tumour necrosis factorα (TNFα) receptor through tumour necrosis factor
receptor type 1-associated DEATHdomain protein (TRADD), or to TNF re-
ceptor associated factor 6 (TRAF6), which links through interleukin-1
receptor-associated kinase (IRAK) and myeloid differentiation prima-
ry response gene 88 (MyD88) to the interleukin-1 (IL-1) receptor. P62 is
also linked to the NF-κB signalling pathway through the association that
it makes with TRAF6 and MEKK3. This complex regulates NF-κB activa-
tion through ubiquitination of the IKKβ complex [10]. It is noteworthy
that both PDE4A4 and MEKK3 bind to the p62 OPCA motif and it
may be possible that a cAMP-dependent switch exists between
NF-κB activation and other p62-organised pathways, such as
autophagosome formation or MEK5-dependent signalling.
Models constructed to investigate the binding modes of p62 partner
proteins have suggested that PKCλ interacts with the p62 PB1 domain,
completely occupying the basic cluster, but leaving the OPCA loop free
[7]. PDE4A4 could presumably bind to the A-type face of the PB1 domain
at the same time as other interactors were binding to the B-type face. In
this manner, the association of the PDE4 would effectively increase the
chances of B-type face binding events as the PDE would maintain the
B-type face in its unphosphorylated state. Thus, with regards to the
aPKCs, increased local cAMP levels could lead to increased PKA activity,
decreasing the bound aPKC level,which is required to activateNF-κB, pro-
viding a novel crosstalk node between the two signalling pathways. Fur-
thermore, the possible inhibitory effect of Ser24 phosphorylation on
autophagy induction could affect other p62-mediated signalling path-
ways as it would enhance p62–partner complexes by saving them from
the fate of autophagy. The bound PDE4A4 could also cause a shift in the
binding equilibrium of the p62 PB1 domain away from the polymerisa-
tion and binding of OPCA motif interactors towards monovalent interac-
tions with the basic PB1 surface (such as aPKC, MEK5, NBR) as it should
lower Ser24 phosphorylation whilst occupying the acidic OPCA motif.
In summary, we have identiﬁed the cAMP-speciﬁc PDE4A4 as a
new direct binding partner of the signalling scaffold p62. Further-
more, p62 was identiﬁed as a new PKA substrate, and phosphoryla-
tion at Ser24 of its PB1 domain has been demonstrated to affect
PB1 domain interaction partner binding. This new signalling axis has
the potential to be harnessed in order to modulate the two main func-
tions of p62: the induction of autophagy through PB1-dependent p62
homopolymerisation and regulation of cellular signalling such as
NF-κB activation through the disruption of the PB1 domain-mediated
binding of aPKCs.
4. Materials and methods
4.1. Plasmids
The plasmids used in this study were obtained through standard
molecular cloning techniques. The plasmids pTH1-p62 (encoding
MBP-p62) and pDest-mCherry-p62 were generously provided by Terje
Johansen [2,32].
The ﬂag-p62 plasmidswere generously provided by Yu-shin Sou [44].
All p62-Ser24 mutants were generated by PCR-based site-directed
mutagenesis using the QuikChange mutagenesis kit (Agilent).
4.2. Cell culture and DNA transfection
HEK293 and PC12 cells were cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM; Sigma-Aldrich) containing 10% fetal bovine serum
(FBS), 5 mM glutamine, and 100 units/ml penicillin/streptomycin at
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transfected with PDE4A4 [45] were cultured in standard HEK293medi-
um supplied with 1 mg/ml G418 sulphate.
4.3. DNA transfection
HEK293 and PC12 cells were transfected using PolyFect reagent
(Qiagen) according to themanufacturer's guidelines and kept in culture
for 24–48 h before experiments were performed.
4.4. Protein expression & puriﬁcation
Proteins were expressed in the E. coli BL21 (DE3) strain in LB medi-
um by induction using 1 mM IPTG at an OD600 of 0.6. Cells were then
grown overnight at 30 °C before being harvested by a 10 min centrifu-
gation at 5000 g and 4 °C. MBP fusion proteins were puriﬁed using am-
ylose afﬁnity resin (New England Biolabs), and GST fusion proteins
using glutathione sepharose (GE Healthcare).
In brief, the cell pelletswere resuspended in 25ml (per litre of initial
culture) ice cold PBS containing protease inhibitors (Complete, Roche)
and 1 mM DTT. The suspension was incubated for 20 min with 30 mg
lysozyme (Sigma) before being lysed by sonication for 10 min on ice.
This lysatewas centrifuged for 45min at 45,000 g to pellet insolublema-
terials. 2 ml of washed amylose resin (MBP) or glutathione sepharose
(GST) was added to the clear supernatant before being rotated for 2 h
at 4 °C. The beads were transferred to a disposable column, washed 5
times with ice cold PBS and eluted three times with either 10mMmalt-
ose (MBP) or 10 mM reduced glutathione solution (GST) in PBS. The
eluted proteins were dialysed three times in protein buffer (50 mM
Tris–HCl pH 8, 100 mM NaCl) and stored at−80 °C until used.
4.5. Immunoblotting antibodies
Sampleswere separated by SDS-PAGE (4–12% gradient Bis/Tris gels)
and transferred to Immobilon-FL PVDF membranes (Millipore) which
were immunoblotted using antibodies against GST (sc-138, Santa Cruz
Biotechnology), ﬂag (A8592, Sigma-Aldrich), p62 (ab56416, Abcam),
GAPDH (MAB374, Millipore), NBR1 (5202, Cell Signaling Technology),
PKCi (2998, Cell Signaling Technology), PKCz (ab51157, Abcam),
MEK5 (AB3184, Millipore), LC3 (ab48394, Abcam), phospho-Akt
(Ser473; 4051, Cell Signaling Technology) and Akt (9272, Cell Signal-
ing Technology).
For speciﬁc detection of Ser24-phosphorylated p62 we commis-
sioned the development of a rabbit polyclonal antiserum based on the
epitope CREIRRFpSF (encompassing R18-F25 of the p62 sequence in
human, mouse and rat; Amsbio). See Fig. S2 for characterisation details.
Quantiﬁcation of Western blots was carried out using densitometry
in the ImageJ software. Details regarding statistical analysis are included
in the ﬁgure legends.
4.6. ELISA
The ELISA to measure protein–protein interactions was carried out
as described earlier [46,47]. Brieﬂy, wells of ELISA plates (3576,
Corning), were coated with GST or GST-PDE4A4 protein (256 nM).
After blocking free binding sites with 0.5% skimmed milk in TBS-T,
either MBP, MBP-p62-wt or MBP-p62-S24Dwere added in various con-
centrations (see Figs. 1A, 4E for details). Plateswerewashedwith TBS-T,
and the amount of bound protein determined using an anti-MBP-HRP
fusion antibody (ab49923, Abcam).
4.7. Peptide array
Peptide libraries were synthesized by automated SPOT synthesis
[17]. Overlapping peptides (25 amino acids in length) were spotted
on Whatman 50 cellulose membranes according to standard protocolsby using Fmoc chemistry with the AutoSpot Robot ASS 222 (Intavis
Bioanalytical Instruments AG). Membranes were overlaid with 10 μg/ml
recombinant GST or GST-PDE4A4. Bound recombinant protein was
detected usingHRP-fused anti-GST (1:2000; Santa Cruz Biotechnology).
Alanine scanning was performed as described [48].
4.8. 32P kinase assay (array + FL)
In order to test phosphorylation of a peptide array through recombi-
nant kinase, the array membrane was blocked overnight with 5%
phosphoblocker (Cell Biolabs) in phosphorylation buffer (20 mM Tris,
150 mM NaCl, 0.5 mM MgCl2, 0.5 mM DTT, 1 mM ATP, pH 7.5) before
being incubated with 0.37 MBq of γ-32P-ATP EasyTides (Perkin Elmer)
and 25 U recombinant PKA catalytic subunit (V5161, Promega) for 30
min at 30 °C. After stringent washing with 1 M NaCl, 5% phosphoric
acid and water, the membranes were dried and exposed for 3 days to
ﬁlm in a Kodak BioMax cassette.
For phosphorylation of puriﬁed full length proteins, 1 μg each of
MBP, MBP-p62-wt, MBP-p62-S24A and MBP-PDE4A4 were diluted
in phosphorylation buffer. For the phosphorylation, 0.37 MBq of
γ-32P-ATP and 0.2 μg of PKA catalytic subunit (60837, Abcam) were
added and the mixture incubated at 30 °C for 30 min. 5× Laemmli
sample buffer was added to the samples which were run on a 4–12%
gradient SDS-PAGE Bis/Tris gel. This was dried and exposed for 3 days
to ﬁlm in a Kodak BioMax cassette.
4.9. Immunoprecipitation
For immunoprecipitations, either native cells or transfected cells
were washed with ice-cold PBS before the addition of lysis buffer
(25 mMHepes, pH 7.5, 2.5 mM EDTA, 225 mMNaCl, 10% (v/v) glycerol,
1% (v/v) Triton X-100, PhosStop phosphatase inhibitor tablets (Roche)
and Complete EDTA-free protease inhibitor cocktail tablets (Roche)).
Lysates were cleared by centrifugation at 14,000 g for 20 min, and pro-
tein content determined by Bradford assay. Lysates containing equal
amounts of protein were then pre-cleared by incubation with Protein
G sepharose (4 Fast Flow, Amersham Biosciences), before immunopre-
cipitation of p62 by the addition of a p62-speciﬁc antibody (ab56416,
Abcam) along with Protein G sepharose overnight at 4 °C. Immunopre-
cipitates were then washed 5×with lysis buffer, and proteins eluted by
the addition of Laemmli sample buffer. Samples were subjected to SDS-
PAGE before being transferred to Immobilon-FL PVDF membrane for
immunoblot.
4.10. Mass spectrometry
Excised protein gel bands were washed, shrunken, and dried in a
vacuum centrifuge. Before tryptic digestion, disulphide bonds were re-
duced with 10 mM DTT in 25 mM ammonium bicarbonate for 45 min
at 55 °C. Alkylation was performed by replacing the DTT solution with
55 mM iodoacetamide in 25 mM ammonium bicarbonate for 20 min
at 25 °C in the dark. The dried gel pieces were incubated with 50 ng of
trypsin (sequencing grade; Promega, Madison, WI) in 20 μl of 50 mM
ammonium bicarbonate at 37 °C overnight. To extract the peptides,
20 μl of 0.5% TFA in acetonitrile was added, and the separated liquid
was taken to dryness under vacuum. For MS analysis, the peptide mix-
ture was dissolved in 6 μl of 0.1% TFA in acetonitrile/water (5:95).
NanoLC–MS/MS experiments were performed on a quadrupole time-
of-ﬂight mass spectrometer, Q-Tof Ultima (Micromass, Manchester,
UK) coupled on a CapLC liquid chromatography system as previously
described [49].
In brief, peptides were separated using an analytical column (Atlan-
tis dC18, 3 μm, 100 Å, 150 mm × 75 μm i.d.; Waters GmbH, Eschborn,
Germany) at an eluent ﬂow rate of 150 nl/min using a linear gradient
4–40% of acetonitrile in 0.1% aqueous formic acid. Data-dependent
acquisition was performed using one MS scan followed by MS/MS
2773F. Christian et al. / Biochimica et Biophysica Acta 1843 (2014) 2765–2774scans of the most abundant peaks. The processed MS/MS spectra and
MASCOT server version 2.0 (Matrix Science Ltd., London, UK) were
used to search in house against the NCBI non-redundant protein da-
tabase (version 20072010). A maximum of two missed cleavages
was allowed, and the mass tolerance of the precursor and sequence
ions was set to 100 ppm and 0.05 Da, respectively. The search in-
cludes carbamidomethyl modiﬁcation of cysteine, methionine oxi-
dation, and phosphorylation of serine or threonine. To identify
phosphorylated peptides, probability-based scoring (MASCOT iden-
tity score, p b 0.05) was used. In addition, tandem mass spectra of
phosphopeptides were manually veriﬁed.
4.11. Fluorescence microscopy
Cells in 6-well-plates transfected with either mCherry-p62-wt or
-S24Dwere observedunder anAxiovert 200Mﬂuorescencemicroscope
(Zeiss) 24 h after transfection using a 40× LD PlanNeoFluar objective.
Several photos were taken from each of several wells transfected
under identical conditions using the ﬁtted AxioCamMR camera. Quanti-
ﬁcation was carried out by counting all cytoplasmic bodies in equally
sized microscopic image sections. For each condition, images from
n = 3 independent experiments were used. Statistical analysis was
done by one-way ANOVA to compare all means (P = 0.0072) and
by unpaired t-test to compare p62-wt vs. -S24A (P = 0.5073; not
signiﬁcant).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.07.021.
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